Qube Research & Technologies (QRT)
SNOA icon

Qube Research & Technologies (QRT)’s Sonoma Pharmaceuticals SNOA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-170
Closed -$722 – 4040
2024
Q2 		$722 Buy
+170
New +$605 ﹤0.01% 3290

Other funds holding SNOA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SNOA Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2024, closing a stake of 170 shares — an estimated $722 sold.

Qube Research & Technologies (QRT) first reported a position in SNOA in Q2 2024 and held it in 1 quarter. The position peaked at $722 in Q2 2024. 14 funds tracked by Wall St. Rank hold SNOA as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Sonoma Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 170 Sonoma Pharmaceuticals shares in Q3 2024, an estimated $722.
  • Qube Research & Technologies (QRT) first reported a position in Sonoma Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Sonoma Pharmaceuticals position peaked at $722 in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.